Non small cell lung cancer cells trang 1 tải miễn phí từ TAILIEUCHUNG

"Non small cell lung cancer cells" trang 1 - tải miễn phí từ Tailieuchung

TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location

TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location

10 43 1

Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells

16 46 1

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells

10 37 1

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

8 40 1

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway

10 60 1

Single-cell transcriptome and antigenimmunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer

Single-cell transcriptome and antigenimmunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer

21 13 1

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation

13 29 1

Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line

Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line

12 24 1

MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer

MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer

7 69 0

Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with nonsmall cell lung cancer

Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with nonsmall cell lung cancer

9 24 1

Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells

Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells

9 39 1

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells

10 32 1

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

8 21 1

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells

Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells

14 76 0

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

Circulating tumor cells prior to initial treatment is an important prognostic factor of survival in non-small cell lung cancer: A meta-analysis and system review

8 12 1

The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFRmutated and -wildtype non-small cell lung cancer cells

The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFRmutated and -wildtype non-small cell lung cancer cells

10 48 1

$Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen$

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

7 45 1

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

11 32 1

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis

13 9 1

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT

15 64 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.